Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.
Adult
Diabetes Mellitus, Type 2
/ epidemiology
Diet, Healthy
/ psychology
Exercise
/ psychology
Female
Glucose Intolerance
/ therapy
Health Promotion
/ methods
Humans
Life Style
Male
Models, Psychological
Prediabetic State
/ epidemiology
Program Evaluation
Research Design
Saudi Arabia
/ epidemiology
Text Messaging
Cardiovascular diseases
Diet
Glycated hemoglobin
Healthy lifestyle
Physical activity
Transtheoretical model
Type 2 diabetes mellitus
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
21 Nov 2019
21 Nov 2019
Historique:
received:
18
04
2019
accepted:
08
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
15
2
2020
Statut:
epublish
Résumé
There is high prevalence of prediabetes and type 2 diabetes mellitus (T2DM) in Saudi Arabia that is still increasing. Early diagnosis of prediabetes, and immediate, effective intervention is yet unestablished. Conventional health promotion approaches are used to educate prediabetic patients. Behavior modification is very effective in prediabetics to delay T2DM. Thus, the main objective of this study is to examine the effect of the new behavioral model, the Transtheoretical Model short messages (text 4 change) to modify lifestyle to prevent or delay the onset of T2DM, through promotion of a healthy diet and increased physical activity, in impaired glucose tolerance patients. Another objective is to estimate the impact of this model on markers of cardiovascular and metabolic risks as T2DM is one of the modifiable risk factors to prevent cardiovascular diseases. This is a randomized controlled trial. One thousand and sixteen, eligible Saudi adults will be recruited from the Heart Health Promotion study (HHP), which was conducted at the King Saud University from July 2013 to April 2014. These adults were at a higher risk of developing T2DM within 2-3 years. The research team's database has a contact list and they will recruit individuals over 6-8 weeks. All participants will be randomized at a 1:1 ratio into two groups, receive group education about lifestyle modifications and written information about diet and physical activity. Text 4 change SMS texts will be sent only to the intervention group. All participants will be assessed at baseline, 6, 12, 18, 24, 30, and 36 months for behavioral change using a World Health Organization (WHO) STEPS questionnaire and for glycated hemoglobin, biochemical and anthropometric measurements using standard methods. This new approach for promoting the importance of behavior modification in prediabetics is expected to delay and/or prevent the development of T2DM in Saudi Arabia, subsequently reducing the risk of cardiovascular morbidity and mortality too. Results from this study will promote an innovative and high-tech way to decrease the burden of cardiovascular diseases in Saudi Arabia. International Standard Randomized Control Trial, registration number ISRCTN10857643. Registered 4 June, 2018.
Sections du résumé
BACKGROUND
BACKGROUND
There is high prevalence of prediabetes and type 2 diabetes mellitus (T2DM) in Saudi Arabia that is still increasing. Early diagnosis of prediabetes, and immediate, effective intervention is yet unestablished. Conventional health promotion approaches are used to educate prediabetic patients. Behavior modification is very effective in prediabetics to delay T2DM. Thus, the main objective of this study is to examine the effect of the new behavioral model, the Transtheoretical Model short messages (text 4 change) to modify lifestyle to prevent or delay the onset of T2DM, through promotion of a healthy diet and increased physical activity, in impaired glucose tolerance patients. Another objective is to estimate the impact of this model on markers of cardiovascular and metabolic risks as T2DM is one of the modifiable risk factors to prevent cardiovascular diseases.
METHODS
METHODS
This is a randomized controlled trial. One thousand and sixteen, eligible Saudi adults will be recruited from the Heart Health Promotion study (HHP), which was conducted at the King Saud University from July 2013 to April 2014. These adults were at a higher risk of developing T2DM within 2-3 years. The research team's database has a contact list and they will recruit individuals over 6-8 weeks. All participants will be randomized at a 1:1 ratio into two groups, receive group education about lifestyle modifications and written information about diet and physical activity. Text 4 change SMS texts will be sent only to the intervention group. All participants will be assessed at baseline, 6, 12, 18, 24, 30, and 36 months for behavioral change using a World Health Organization (WHO) STEPS questionnaire and for glycated hemoglobin, biochemical and anthropometric measurements using standard methods.
DISCUSSION
CONCLUSIONS
This new approach for promoting the importance of behavior modification in prediabetics is expected to delay and/or prevent the development of T2DM in Saudi Arabia, subsequently reducing the risk of cardiovascular morbidity and mortality too. Results from this study will promote an innovative and high-tech way to decrease the burden of cardiovascular diseases in Saudi Arabia.
TRIAL REGISTRATION
BACKGROUND
International Standard Randomized Control Trial, registration number ISRCTN10857643. Registered 4 June, 2018.
Identifiants
pubmed: 31752774
doi: 10.1186/s12889-019-7921-8
pii: 10.1186/s12889-019-7921-8
pmc: PMC6873582
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1550Références
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Circulation. 1989 Jan;79(1):8-15
pubmed: 2642759
Am J Prev Med. 2009 Feb;36(2):165-73
pubmed: 19135907
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
Circulation. 2004 Jul 13;110(2):227-39
pubmed: 15249516
J Diabetes. 2015 Sep;7(5):622-32
pubmed: 25266306
Nutr Res Pract. 2017 Jun;11(3):247-256
pubmed: 28584582
Health Promot Pract. 2006 Oct;7(4):428-43
pubmed: 16840769
Diabetes Care. 2010 Jul;33(7):1665-73
pubmed: 20587727
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
Diabet Med. 2007 Feb;24(2):200-7
pubmed: 17257284
Addict Behav. 2015 Mar;42:176-9
pubmed: 25481450
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Diabetes Care. 1998 Sep;21(9):1408-13
pubmed: 9727885
Sports Med. 2004;34(1):1-8
pubmed: 14715035
JAMA. 1995 Feb 1;273(5):402-7
pubmed: 7823386
J Diabetes Res. 2016;2016:1219581
pubmed: 26798647
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
Circulation. 2016 Feb 9;133(6):592-600
pubmed: 26769742
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
BMC Fam Pract. 2008 Apr 11;9:20
pubmed: 18405345
N Engl J Med. 2005 Oct 6;353(14):1454-62
pubmed: 16207847
Int J Endocrinol. 2012;2012:902873
pubmed: 22851968
Aust Fam Physician. 2006 Mar;35(3):175-6
pubmed: 16525536
Patient Educ Couns. 2014 Jun;95(3):384-92
pubmed: 24726785
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Diabetes Care. 1999 Jun;22(6):920-4
pubmed: 10372242
Eat Behav. 2015 Apr;17:37-44
pubmed: 25553558
PLoS One. 2016 Apr 01;11(4):e0152559
pubmed: 27035920
Ann Behav Med. 1998 Summer;20(3):174-80
pubmed: 9989324
Diabetes Care. 1992 Jul;15(7):820-5
pubmed: 1516498
PLoS One. 2016 Nov 4;11(11):e0165036
pubmed: 27814369
Diabetes. 2003 Jun;52(6):1475-84
pubmed: 12765960
Diabetes Care. 1999 Jun;22(6):883-5
pubmed: 10372235